Anesthetic Efficacy of 2% Mepivacaine Versus 4% Articaine

• Status: Unknown status
• Trial end date: 2018-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this prospective randomized clinical trial was compare between 2% Mepivacaine and 4% Articaine for inferior alveolar nerve blocks in patients with symptomatic irreversible pulpitis in mandibular molars as regards to their anesthetic efficiency; during access cavity preparation and instrumentation.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cairo University
• Treatments: Anesthetics; Carticaine; Epinephrine; Mepivacaine

Criteria

Inclusion Criteria:

1. Patients in good health (American Society of Anesthesiologists Class II or higher)

2. Patients having symptomatic irreversible pulpitis in one of their mandibular molars.

3. Age range is between 20 and 50 years.

4. Patients who can understand Visual Analogue Scales VAS.

5. Patients able to sign informed consent

Exclusion Criteria:

1. Patients allergic to articaine and/or mepivacaine and/or sulfur

2. Patients having active sites of pathosis in the area of injection.

3. Patients having active pain in more than one molar.

4. Patients who had taken analgesics in the 12 hours preceding the injection.